VANGUARD GROUP INC 13D and 13G filings for OPKO Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:54 pm Unchanged | 2024-09-30 | 13G | OPKO HEALTH, INC OPK | VANGUARD GROUP INC | 29,218,150 4.180% | 0 (Unchanged) | Filing |
| 2024-11-04 1:24 pm Sale | 2024-09-30 | 13G | OPKO HEALTH, INC OPK | VANGUARD GROUP INC | 29,218,150 4.180% | -10,533,143 (-26.50%) | Filing |
| 2024-02-13 5:12 pm Sale | 2023-12-29 | 13G | OPKO HEALTH, INC OPK | VANGUARD GROUP INC | 39,751,293 5.140% | -1,369,201 (-3.33%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | OPKO HEALTH, INC OPK | VANGUARD GROUP INC | 41,120,494 5.320% | 5,395,070 (+15.10%) | Filing |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | OPKO HEALTH, INC OPK | VANGUARD GROUP INC | 35,725,424 5.240% | 1,275,270 (+3.70%) | Filing |